Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
- PMID: 29202557
- PMCID: PMC5768549
- DOI: 10.3904/kjim.2017.343
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and the prevalence of non-alcoholic steatohepatitis (NASH) with fibrosis is increasing as the population with NAFLD ages. To date, lifestyle modifications including weight loss, increased physical activity, and dietary changes remain the treatment of choice for NAFLD because there are no approved effective pharmacologic agents. Increased physical activity has therapeutic effects on NAFLD by reducing hepatic fat independent of weight reduction. Indeed, even minimal physical activity below the recommended threshold may have a beneficial impact on NAFLD. Aerobic activity and resistance training have similar effects on NAFLD. Universal recommendations for the optimal intensity and dose of physical activity have not been established. Therefore, physical activity should be tailored based on a patient's clinical characteristics, comorbidities, and fitness capacity. Physical activity also prevents the development of NAFLD and may represent a valuable strategy for reducing the public health burden. However, there are insufficient data supporting the effects of physical activity on the progression of non-alcoholic fatty liver to NASH with advanced fibrosis, and on extrahepatic disease-related morbidity and mortality. In this paper, we review the role of physical activity in the management of NAFLD.
Keywords: Exercise; Hepatic steatosis; Life-style modification.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835. Curr Vasc Pharmacol. 2018. PMID: 28637408 Review.
-
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.Dig Dis Sci. 2016 May;61(5):1365-74. doi: 10.1007/s10620-016-4153-y. Dig Dis Sci. 2016. PMID: 27052013 Review.
-
Treatment of NAFLD with diet, physical activity and exercise.J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23. J Hepatol. 2017. PMID: 28545937 Review.
-
Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.Metabolism. 2017 Mar;68:119-132. doi: 10.1016/j.metabol.2016.12.006. Epub 2016 Dec 16. Metabolism. 2017. PMID: 28183444 Review.
-
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered.Nutrients. 2019 Dec 5;11(12):2971. doi: 10.3390/nu11122971. Nutrients. 2019. PMID: 31817398 Free PMC article. Review.
Cited by
-
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond.Biomedicines. 2024 Feb 8;12(2):397. doi: 10.3390/biomedicines12020397. Biomedicines. 2024. PMID: 38397999 Free PMC article. Review.
-
Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation.Antioxidants (Basel). 2020 Sep 1;9(9):808. doi: 10.3390/antiox9090808. Antioxidants (Basel). 2020. PMID: 32882802 Free PMC article.
-
Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients. 2019 Nov 26;11(12):2878. doi: 10.3390/nu11122878. Nutrients. 2019. PMID: 31779112 Free PMC article. Review.
-
Comparing the Efficacy and Safety of Obeticholic Acid and Semaglutide in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review.Cureus. 2022 May 8;14(5):e24829. doi: 10.7759/cureus.24829. eCollection 2022 May. Cureus. 2022. PMID: 35693370 Free PMC article. Review.
-
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors.Metabolites. 2025 May 9;15(5):318. doi: 10.3390/metabo15050318. Metabolites. 2025. PMID: 40422894 Free PMC article.
References
-
- Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the united states and the rest of the world. Clin Liver Dis. 2016;20:205–214. - PubMed
-
- Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–530. - PubMed
-
- Satapathy SK, Sanyal AJ. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin Liver Dis. 2015;35:221–235. - PubMed
-
- Kwak MS, Kim D. Long-term outcomes of nonalcoholic fatty liver disease. Curr Hepatol Rep. 2015;14:69–76.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical